Member Info for Veteran10

Well tbh, I would be amazed if we are not on the list. The last 10 years seems proof enough.

Fruit - I think you can forgive me for being hot headed then.

Received it this afternoon

Thank you for your enquiry and for your patience as we have responded to queries.

There was a rapid improvement in standard of care over the course of the pandemic. When the Phase 2 study was conducted, no patients in the Phase 2 study received systemic corticosteroids for COVID-19 at baseline whereas at the time when the Phase 3 SPRINTER trial was conducted, 87% of patients did. Additionally, unlike in the Phase 2 study, many patients in the Phase 3 study also received the direct acting antiviral remdesivir. This change in standard of care may have compromised the potential of SNG001 to show a clinical benefit in SPRINTER.

As announced on 21st February, we are reviewing the study's full dataset to better understand the detailed results and implications for development of SNG001 and will provide an update as soon as possible as in accordance with our stock market listing rules. While the overall study outcome is disappointing, we have observed an encouraging trend in prevention of progression to severe disease and death (36. 3% in the per protocol population), which we and our clinical advisors strongly believe merits further investigation in a large platform trial. We are exploring trials that might be suitable.

The study results will also be submitted for peer review with a goal of being accepted for presentation and/or publication as soon as possible.

In the meantime, we eagerly await the Phase 2 data from the US NIH ACTIV-2 trial in home- based COVID-19 patients, and that trial’s larger, follow-on Phase 3 study, as part of the development path for SNG001. Once available, we will review the Phase 2 data from the US NIH ACTIV-2 trial in home-based COVID-19 patients treated earlier in the course of the infection.

During the conduct of a clinical trial, the results remain confidential to the sponsors until all data has been collected, statistically analysed and quality controlled. This is to avoid any bias and premature disclosure. The statisticians passed us the quality-controlled data and the results were announced in line with financial reporting obligations.

As one would expect, in readiness for a potential favourable outcome of the SPRINTER trial, several operational plans were progressed (as announced to the LSE such as Ashfield and a general scale up of operations) to ensure we would be in a position to rapidly execute our regulatory and launch plans for this global health emergency.

As the world prepares to live with COVID-19, we recognize the importance of well-tolerated treatments and the need to ensure preparedness for future pandemics and thank you for your continued support

Brooke

Brooke S Clarke
Senior Vice President, Head of Communications
Synairgen

Not as exposed as many were. Only had 2000 shares. Have increased that to 10000 now so need 36p to break even. We will see. Do feel we could spike out of nowhere.

I think the rise could be more to do with Ferrexpo and speculators thinking the situation with Ukraine and their mines there, means Zanaga is now more likely to be developed. It feels uncomfortable to say it as what we have seen this week is both vile and heartbreaking yet the chances of Zanaga being developed or bought out have now increased as a result.

Surprised we are not higher when you look at BOR today. It will be alot easier to get our gas out than their's!

You would think quite a few Western countries would be looking at alternative gas sources (understatement!!!). The value of Chariot's discovery has gone up. Fill your boots at this price.

Some large buys which is interesting. I am not running around in the garden in my underpants like you yet Rambo though.

F in Putin

Sensational. Sounds like ramping but how can anyone not say that to exceed the last 4 months of sales in 6 weeks is anything less than sensational. Yesterday's drop here was a joke. Without Omicrom and Putin we would be nearer 50p than 30p.

Alot of people would sell at 12p if they could. Still radio silence from Zioc.

I think that is the where the company need to come out and speak via Proactive Investors or similar. Do they have nothing or is there still hope. No doubt today is a brutal lesson for some. Always diversify. How many fund managers hold more than 10% of a fund in one stock. Very few.

They have no product. It's crap.

Wow very dodgy here. I hope the management team will be resigning. No credibility and cannot be trusted to run the company.

Been thinking the same. This is going to fly soon. Loaded and ready to reap the gains ??

Posted before but some replies I received to questions-

Yes , licensing MicroSalt as an ingredient is within our target circle of activity. As soon as we have movement on this issue, I am sure that a Press Release will be sent.

Thanks

Rick Guiney
CEO, MicroSalt, Inc
561-516-1967



Thank you for the note and we agree, the foodservice french fry market is one that we are very interested in.


We have ongoing dialogue with product delivery specialists to help us design, test, and ultimately activate a MicroSalt delivery system customized for "back of the house" salt applications.


As soon as a solution is ready to roll out, rest assured the entire market, not just McDonalds will be our target.


Thank You again


Rick Guiney

CEO, MicroSalt, Inc

561-516-1967

rguiney@microsaltinc.com

Kind of kills a joke when you have to explain it Scott.

Here's a better one for you-

What's Irish and stays outside all year?

Paddy O'Furniture

Have a good night!

Try 150p IC

10p off of highs so a very good entry price here. Must be IPO news soon on Lucyd. I thought we would be 50p plus now and without the macro issues in the world we very likely would have been.